Hair loss news – Hair loss and how to prevent it

MicroRNA That Shows Promise for Hair Regrowth

MicroRNA That Shows Promise for Hair Regrowth

Researchers Identify MicroRNA That Shows Promise for Hair Regrowth

Researchers from North Carolina State University have identified a microRNA (miRNA) that could promote hair regeneration. This miRNA – miR-218-5p – plays an important role in regulating the pathway involved in follicle regeneration and could be a candidate for future drug development.

Hair growth depends on the health of dermal papillae (DP) cells, which regulate the hair follicle growth cycle. Current treatments for hair loss can be costly and ineffective, ranging from invasive surgery to chemical treatments that don’t produce the desired result.

Recent hair loss research indicates that hair follicles don’t disappear where balding occurs, they just shrink. If DP cells could be replenished at those sites, the thinking goes, then the follicles might recover.

A research team led by Ke Cheng, Randall B. Terry, Jr. Distinguished Professor in Regenerative Medicine at NC State’s College of Veterinary Medicine and professor in the NC State/UNC Joint Department of Biomedical Engineering, cultured DP cells both alone (2D) and in a 3D spheroid environment. A spheroid is a three-dimensional cellular structure that effectively recreates a cell’s natural microenvironment.

In a mouse model of hair regeneration, Cheng looked at how quickly hair regrew on mice treated with 2D cultured DP cells, 3D spheroid-cultured DP cells in a keratin scaffolding, and the commercial hair loss treatment Minoxidil. In a 20-day trial, mice treated with the 3D DP cells had regained 90% of hair coverage at 15 days.

“The 3D cells in a keratin scaffold performed best, as the spheroid mimics the hair microenvironment and the keratin scaffold acts as an anchor to keep them at the site where they are needed,” Cheng says. “But we were also interested in how DP cells regulate the follicle growth process, so we looked at the exosomes, specifically, exosomal miRNAs from that microenvironment.” Exosomes are tiny sacs secreted by cells that play an important role in cell to cell communication. Those sacs contain miRNAs.

MiRNAs are small molecules that regulate gene expression. Cheng and his team measured miRNAs in exosomes derived from both 3D and 2D DP cells. In the 3D DP cell-derived exosomes, they pinpointed miR-218-5p, a miRNA that enhances the molecular pathway responsible for promoting hair follicle growth. They found that increasing miR-218-5p promoted hair follicle growth, while inhibiting it caused the follicles to lose function.

“Cell therapy with the 3D cells could be an effective treatment for baldness, but you have to grow, expand, preserve and inject those cells into the area,” Cheng says. “MiRNAs, on the other hand, can be utilized in small molecule-based drugs. So potentially you could create a cream or lotion that has a similar effect with many fewer problems. Future studies will focus on using just this miRNA to promote hair growth.”

The research appears in Science Advances, and was supported by the National Institutes of Health and the American Heart Association. Cheng is corresponding author. Postdoctoral researcher Shiqi Hu is first author.

-peake-

“Dermal exosomes containing miR-218-5p promote hair regeneration by regulating β-catenin signaling”

DOI: 10.1126/sciadv.aba1685

Authors: Shiqi Hu, Zhenhua Li, Halle Lutz, Teng Su, Ke Cheng, North Carolina State University College of Veterinary Medicine and the NC State/UNC Joint Department of Biomedical Engineering; Ke Huang, Jhon Cores, Phuong-Uyen Cao Dinh, North Carolina State University College of Veterinary Medicine

Published: July 24, in Science Advances

Abstract: The progression in the hair follicle cycle from the telogen to the anagen phase is the key to regulating hair regrowth. Dermal papilla (DP) cells support hair growth and regulate the hair cycle. However, they gradually lose key inductive properties upon culture. DP cells can partially restore their capacity to promote hair regrowth after being subjected to spheroid culture. In this study, results revealed that DP spheroids are effective at inducing the progression of the hair follicle cycle from telogen to anagen compared with just DP cell or minoxidil treatment.

Because of the importance of paracrine signaling in this process, secretome and exosomes were isolated from DP cell culture, and their therapeutic efficacies were investigated. We demonstrated that miR-218-5p was notably up-regulated in DP spheroid–derived exosomes. Western blot and immunofluorescence imaging were used to demonstrate that DP spheroid–derived exosomes down-regulated the secreted frizzled-related protein 2 and up-regulated β-catenin, promoting the development of hair follicles.

Researchers Identify MicroRNA That Shows Promise for Hair Regrowth

Source

Recent Posts

Alopecia Areata- Market Insight

Alopecia Areata- Market Insight

Alopecia Areata- Market Insight, Epidemiology and Market Forecast -2030

Alopecia Areata Market

DelveInsight’s “Alopecia Areata – Market Insights, Epidemiology, and Market Forecast-2030″ report delivers an in-depth understanding of the Alopecia Areata, historical and forecasted epidemiology as well as the Alopecia Areata market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

The Alopecia Areata market report provides current treatment practices, emerging drugs, Alopecia Areata market share of the individual therapies, current and forecasted Alopecia Areata market Size from 2017 to 2030 segmented by seven major markets. The Report also covers current Alopecia Areata treatment practice/algorithm, market drivers, market barriers and unmet medical needs to curate best of the opportunities and assesses the underlying potential of the market.

Geography Covered

  • The United States
  • EU5 (Germany, France, Italy, Spain, and the United Kingdom)
  • Japan

Study Period: 2017-2030

Alopecia Areata Disease Understanding and Treatment Algorithm

The DelveInsight Alopecia Areata market report gives a thorough understanding of the Alopecia Areata by including details such as disease definition, symptoms, causes, pathophysiology, diagnosis and treatment.

Diagnosis

This segment of the report covers the detailed diagnostic methods or tests for Alopecia Areata.

Treatment

It covers the details of conventional and current medical therapies available in the Alopecia Areata market for the treatment of the condition. It also provides Alopecia Areata treatment algorithms and guidelines in the United States, Europe, and Japan.

Alopecia Areata Epidemiology 

The Alopecia Areata epidemiology division provides insights about historical and current Alopecia Areata patient pool and forecasted trend for every seven major countries. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. This part of the DelveInsight report also provides the diagnosed patient pool and their trends along with assumptions undertaken.

Key Findings

The disease epidemiology covered in the report provides a historical as well as forecasted Alopecia Areata epidemiology scenario in the 7MM covering the United States, EU5 countries (Germany, Spain, Italy, France, and the United Kingdom), and Japan from 2017 to 2030.

Country Wise- Alopecia Areata Epidemiology

The epidemiology segment also provides the Alopecia Areata epidemiology data and findings across the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan.

Alopecia Areata Drug Chapters

The drug chapter segment of the Alopecia Areata report encloses the detailed analysis of Alopecia Areata marketed drugs and late stage (Phase-III and Phase-II) pipeline drugs. It also helps to understand the Alopecia Areata clinical trial details, expressive pharmacological action, agreements and collaborations, approval and patent details, advantages and disadvantages of each included drug and the latest news and press releases.

Marketed Drugs

The report provides the details of the marketed product available for Alopecia Areata treatment.

Alopecia Areata Emerging Drugs

The report provides the details of the emerging therapies under the late and mid-stage of development for Alopecia Areata treatment.

Alopecia Areata Market Outlook

The Alopecia Areata market outlook of the report helps to build the detailed comprehension of the historic, current, and forecasted Alopecia Areata market trends by analyzing the impact of current therapies on the market, unmet needs, drivers and barriers and demand for better technology.

This segment gives a thorough detail of Alopecia Areata market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on an annual cost of therapy, inclusion and exclusion criteria’s, mechanism of action, compliance rate, growing need of the market, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders. The calculated market data are presented with relevant tables and graphs to give a clear view of the market at first sight.

According to DelveInsight, the Alopecia Areata market in 7MM is expected to change in the study period 2017-2030.

Key Findings

This section includes a glimpse of the Alopecia Areata market in 7MM.

The United States Market Outlook

This section provides the total Alopecia Areata market size and market size by therapies in the United States.

EU-5 Countries: Market Outlook

The total Alopecia Areata market size and market size by therapies in Germany, France, Italy, Spain, and the United Kingdom is provided in this section.

Japan Market Outlook

The total Alopecia Areata market size and market size by therapies in Japan is also mentioned.

Alopecia Areata Drugs Uptake

This section focuses on the rate of uptake of the potential drugs recently launched in the Alopecia Areata market or expected to get launched in the market during the study period 2017-2030. The analysis covers Alopecia Areata market uptake by drugs; patient uptake by therapies; and sales of each drug.

This helps in understanding the drugs with the most rapid uptake, reasons behind the maximal use of new drugs and allow the comparison of the drugs on the basis of market share and size which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions.

Alopecia Areata Pipeline Development Activities

The report provides insights into different therapeutic candidates in Phase II, and Phase III stages. It also analyses Alopecia Areata key players involved in developing targeted therapeutics.

Pipeline Development Activities

The report covers the detailed information of collaborations, acquisition and merger, licensing, patent details and other information for Alopecia Areata emerging therapies.

Reimbursement Scenario in Alopecia Areata

Approaching reimbursement proactively can have a positive impact both during the late stages of product development and well after product launch. In a report, we take reimbursement into consideration to identify economically attractive indications and market opportunities. When working with finite resources, the ability to select the markets with the fewest reimbursement barriers can be a critical business and price strategy.

KOL- Views

To keep up with current market trends, we take KOLs and SME’s opinions working in the Alopecia Areata domain through primary research to fill the data gaps and validate our secondary research. Their opinion helps to understand and validate current and emerging therapies treatment patterns or Alopecia Areata market trends. This will support the clients in potential upcoming novel treatment by identifying the overall scenario of the market and the unmet needs.

Competitive Intelligence Analysis

We perform Competitive and Market Intelligence analysis of the Alopecia Areata Market by using various Competitive Intelligence tools that include – SWOT analysis, PESTLE analysis, Porter’s five forces, BCG Matrix, Market entry strategies etc. The inclusion of the analysis entirely depends upon the data availability.

Scope of the Report

  • The report covers the descriptive overview of Alopecia Areata, explaining its causes, signs and symptoms, pathophysiology, diagnosis and currently available therapies
  • Comprehensive insight has been provided into the Alopecia Areata epidemiology and treatment in the 7MM
  • Additionally, an all-inclusive account of both the current and emerging therapies for Alopecia Areata is provided, along with the assessment of new therapies, which will have an impact on the current treatment landscape
  • A detailed review of the Alopecia Areata market; historical and forecasted is included in the report, covering drug outreach in the 7MM
  • The report provides an edge while developing business strategies, by understanding trends shaping and driving the global Alopecia Areata market

Report Highlights

  • In the coming years, the Alopecia Areata market is set to change due to the rising awareness of the disease, and incremental healthcare spending across the world; which would expand the size of the market to enable the drug manufacturers to penetrate more into the market
  • The companies and academics are working to assess challenges and seek opportunities that could influence Alopecia Areata R&D. The therapies under development are focused on novel approaches to treat/improve the disease condition
  • Major players are involved in developing therapies for Alopecia Areata. The launch of emerging therapies will significantly impact the Alopecia Areata market
  • A better understanding of disease pathogenesis will also contribute to the development of novel therapeutics for Alopecia Areata
  • Our in-depth analysis of the pipeline assets across different stages of development (Phase III and Phase II), different emerging trends and comparative analysis of pipeline products with detailed clinical profiles, key cross-competition, launch date along with product development activities will support the clients in the decision-making process regarding their therapeutic portfolio by identifying the overall scenario of the research and development activities

Alopecia Areata Report Insights

  • Patient Population
  • Therapeutic Approaches
  • Alopecia Areata Pipeline Analysis
  • Alopecia Areata Market Size and Trends
  • Market Opportunities
  • Impact of upcoming Therapies

Alopecia Areata Report Key Strengths

  • 11 Years Forecast
  • 7MM Coverage
  • Alopecia Areata Epidemiology Segmentation
  • Key Cross Competition
  • Highly Analyzed Market
  • Drugs Uptake

Alopecia Areata Report Assessment

  • Current Treatment Practices
  • Unmet Needs
  • Pipeline Product Profiles
  • Market Attractiveness
  • Market Drivers and Barriers

Key Questions

Market Insights:

  • What was the Alopecia Areata market share (%) distribution in 2017 and how it would look like in 2030?
  • What would be the Alopecia Areata total market size as well as market size by therapies across the 7MM during the forecast period (2017-2030)?
  • What are the key findings pertaining to the market across 7MM and which country will have the largest Alopecia Areata market size during the forecast period (2017-2030)?
  • At what CAGR, the Alopecia Areata market is expected to grow in 7MM during the forecast period (2017-2030)?
  • What would be the Alopecia Areata market outlook across the 7MM during the forecast period (2017-2030)?
  • What would be the Alopecia Areata market growth till 2030, and what will be the resultant market Size in the year 2030?
  • How would the market drivers, barriers and future opportunities affect the market dynamics and subsequent analysis of the associated trends?

Epidemiology Insights:

  • What is the disease risk, burden and unmet needs of the Alopecia Areata?
  • What is the historical Alopecia Areata patient pool in seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan?
  • What would be the forecasted patient pool of Alopecia Areata in seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan?
  • What will be the growth opportunities in the 7MM with respect to the patient population pertaining to Alopecia Areata?
  • Out of all 7MM countries, which country would have the highest prevalent population of Alopecia Areata during the forecast period (2017-2030)?
  • At what CAGR the population is expected to grow in 7MM during the forecast period (2017-2030)?

Current Treatment Scenario, Marketed Drugs and Emerging Therapies:

  • What are the current options for the Alopecia Areata treatment, along with the approved therapy?
  • What are the current treatment guidelines for the treatment of Alopecia Areata in the USA, Europe, and Japan?
  • What are the Alopecia Areata marketed drugs and their MOA, regulatory milestones, product development activities, advantages, disadvantages, safety and efficacy, etc.?
  • How many companies are developing therapies for the treatment of Alopecia Areata?
  • How many therapies are developed by each company for Alopecia Areata treatment?
  • How many are emerging therapies in mid-stage, and late stage of development for Alopecia Areata treatment?
  • What are the key collaborations (Industry – Industry, Industry – Academia), Mergers and acquisitions, licensing activities related to the Alopecia Areata therapies?
  • What are the recent novel therapies, targets, mechanisms of action and technologies developed to overcome the limitation of existing therapies?
  • What are the clinical studies going on for Alopecia Areata and their status?
  • What are the key designations that have been granted for the emerging therapies for Alopecia Areata?
  • What are the global historical and forecasted market of Alopecia Areata?

Reasons to buy

  • The report will help in developing business strategies by understanding trends shaping and driving the Alopecia Areata market
  • To understand the future market competition in the Alopecia Areata market and Insightful review of the key market drivers and barriers
  • Organize sales and marketing efforts by identifying the best opportunities for Alopecia Areata in the US, Europe (Germany, Spain, Italy, France, and the United Kingdom) and Japan
  • Identification of strong upcoming players in the market will help in devising strategies that will help in getting ahead of competitors
  • Organize sales and marketing efforts by identifying the best opportunities for Alopecia Areata market
  • To understand the future market competition in the Alopecia Areata market

Alopecia Areata- Market Insight, Epidemiology and Market Forecast -2030

Source

Recent Posts

Aesthetics Treatments for Body Improvement

Aesthetics Treatments for Body Improvement

ABM Launches Three Medical Procedures Aesthetics Treatments for Body Improvement

ABM Medical Clinic & Cosmetics, a top-rated clinic for body improvements and facial aesthetics, is proud to announce the addition of three new aesthetic medical procedures. The new body rejuvenation treatments include PRP (Platelet-Rich Plasma) Facial, PRP Therapy for Hair Loss, and Vampire Facial.

Our PRP Facial cosmetic procedure helps tighten the skin and quickens the healing process. Whether wrinkles, age spots, scarring, or hyperpigmentation, our team of board-certified physicians uses a minimally invasive treatment to remove scars, improve skin tone and texture, boost collagen and elastin, and rejuvenate the skin.

We combine both traditional micro needling and modern collagen induction therapy to improve effects and achieve faster results. Our PRP facial procedure is proven to be safe with no chance for allergic reactions because the plasma comes from your own body.

In addition, ABM Medical Clinic & Cosmetic is happy to introduce an innovative hair loss treatment.

Our PRP Hair Loss medical procedure is a product of years of consistently exploring the best options for hair loss solutions. This three-step medical hair restoration procedure uses PRP to trigger healthy hair growth in dying hair follicles.

It also increases the thickness of the hair shaft, helping you revitalize natural hair. Our hair restoration strategy is for women and men seeking the best alternative to hair transplant surgery by appropriately fixing hair loss.

We have also added a nonsurgical cosmetic procedure called Vampire Facial to help men and women offset ageing effects like hollowed-out skin, crow’s feet, bumps, and certain skin deformities. Our Vampire Facial clinical procedure uses cellular therapy to rejuvenate the skin and provide a youthful, natural, and healthy appearance without the need for plastic surgery. It is a non-invasive cosmetic procedure that requires only topical anaesthesia.

We are committed to providing you with the healthiest skin and body, keeping you in the best physical state regardless of age. For more information about our process and to book a free consultation:

ABM Launches Three Medical Procedures Aesthetics Treatments for Body Improvement

Source

Recent Posts

Anti-dandruff Agent Additive Market

Anti-dandruff Agent Additive Market

Global Anti-dandruff Agent Additive Market Insights and Forecast to 2027

Market Analysis and Insights: Global Anti-dandruff Agent Additive Market

The global Anti-dandruff Agent Additive market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.

Global Anti-dandruff Agent Additive Scope and Segment

Anti-dandruff Agent Additive market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Anti-dandruff Agent Additive market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2016-2027.

The following manufacturers are covered in this report:

Clariant AG

Aurora Chemical

Spec Chem Group

Kumar Organic

Chemspec Chemicals

3C Pharmchem

Somu Group

Kolon Life Science

Regen Chemical

Symrise

Tinci Materials

Seqens SAS

Merck KGaA

Plater Group

Gaopeng Pharmaceutical

Kavya Pharma

Fengchen Technology

Xi’an Taicheng Chem

Anti-dandruff Agent Additive Breakdown Data by Type

Piroctone Olamine

Climbazole

Slaicylic Acid

Ketoconazole

Coal Tar

Selenium Sulfide

Other

Anti-dandruff Agent Additive Breakdown Data by Application

Personal Care

Pharmaceutical

Regional and Country-level Analysis

The Anti-dandruff Agent Additive market is analysed and market size information is provided by regions (countries).

The key regions covered in the Anti-dandruff Agent Additive market report are North America, Europe, China and Japan. It also covers key regions (countries), viz, the United States, Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Mexico, Brazil, Turkey, Saudi Arabia, UAE, etc.

The report includes a country-wise and region-wise market size for the period 2016-2027. It also includes market size and forecast by Type, and Application segment in terms of production capacity, price and revenue for the period 2016-2027.

Global Anti-dandruff Agent Additive Market Insights and Forecast to 2027

Source

Recent Posts

Hair Products Cause Hair Loss

Hair Products Cause Hair Loss

Johnson & Johnson Hair Products Cause Hair Loss, Lawsuit Claims

A class-action lawsuit has been filed against Johnson & Johnson with the claim that the company’s OGX hair care products cause significant hair loss.

The products are sold at major national retailers, including Target, Ulta, CVS, Walmart, and Walgreens. Johnson & Johnson shampoos, conditioners, and some hair oils are among the products named in the lawsuit.

The plaintiff, Larissa Whipple, an Illinois woman, cites the ingredient DMDM hydantoin as the main concern. DMDM hydantoin is a preservative and antimicrobial agent sometimes found in hair care products. It’s considered a “formaldehyde donor,” meaning it releases a small amount of formaldehyde overtime to keep the product fresh.

But formaldehyde donors like this one have been linked to allergies, rashes, hair loss, and cancer. The Department of Health and Human Services’ National Toxicology Program has said formaldehyde is known to cause cancer.

The lawsuit says that the company may have violated consumer protection laws by advertising the products containing this ingredient to people who want healthy hair.

“Johnson & Johnson made a number of affirmative misrepresentations … that the products ‘deeply nourish’, ‘gently cleanse,’ and ‘repair hair.’ However, the products’ formula contains an ingredient, or combination of ingredients, that has caused Plaintiff and thousands of consumers to experience hair loss and/or scalp irritation,” the lawsuit says.

Johnson & Johnson says all their ingredients are carefully selected and are listed on the products’ label. The company stated that none of their new products contains DMDM hydantoin and they have not launched any new hair products with this ingredient in several years.

“We carefully select ingredients to ensure the safety and performance of our products,” Johnson & Johnson said in a statement to WebMD. “Some of our existing products contain a small amount of DMDM hydantoin, which is used to prevent mould from developing while the product is in the shower. Every preservative used in our products must clear our rigorous safety assessment process.”

In August 2012, Johnson & Johnson announced it would remove DMDM hydantoin and other similar ingredients from their products by 2015. However, the lawsuit says that is a “broken promise.”

“Johnson & Johnson did in fact remove DMDM hydantoin from existing consumer products at that time,” the lawsuit says. “However, when Johnson & Johnson acquired Vogue International, including their line of OGX products, Johnson & Johnson failed to change the ingredient profile of the products that did not maintain the same standards for consumer safety.”

In the preservatives section of Johnson & Johnson’s safety and care commitment website, the company claims DMDM hydantoin does not meet their safety standards, but further down the page they say they use DMDM hydantoin in products when other preservatives are incompatible with other ingredients in a formula.

Dermatologist Shani Francis, MD, says hair product manufacturers should be striving to create a positive experience for their customers.

“Hair breakage and texture changes are important clues to pay attention to regarding overall hair health. We should always seek out products to enhance our hair care experience,” Francis says. “Having a great understanding of your individual hair needs is most important to avoid problems.”

DMDM hydantoin is listed by the FDA as one of the preservatives found to cause the most allergic reactions from the use of cosmetic products. The FDA requires certain products to list ingredients, but some ingredients may not be specifically identified and instead listed as “fragrance” or “perfume.”

Francis says an important thing to remember is that there is no “one size fits all” for hair care products and seeking out products with a company history of strong customer experience is a good way to look for new products.

“For ingredients, water-based products are generally a good place to start. Aloe vera high in the ingredient list suggests a more acidic pH. Glycerin also is a humectant that can help naturally add moisture to the hair,” Francis says. “Ultimately, balance is most important. Often[times], too much of a good thing is not a good thing. Additionally, if you have an underlying medical, scalp or skin condition, you could have a unique situation and should seek the help of a board-certified dermatologist.”

Johnson & Johnson Hair Products Cause Hair Loss, Lawsuit Claims

Source

Recent Posts

Scalp Microneedling Market

Scalp Microneedling Market

2021-2027 Global Scalp Microneedling Market Report – Production and Consumption Professional Analysis (Impact of COVID-19)

Description_

This report elaborates the market size, market characteristics, and market growth of the Scalp Microneedling industry, and breaks it down according to the type, application, and consumption area of Scalp Microneedling.

The report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry.

In Chapter 3.4 of the report, the impact of the COVID-19 outbreak on the industry was fully assessed. Fully risk assessment and industry recommendations were made for Scalp Microneedling in a special period. This chapter also compares the markets of Pre COVID-19 and Post COVID-19.

In addition, chapters 8-12 consider the impact of COVID-19 on the regional economy.

Key players in the global Scalp Microneedling market covered in Chapter 13

Lotus
Yonghe Hair Transplant
zcalp

In Chapter 6, on the basis of types, the Scalp Microneedling market from 2015 to 2025 is primarily split into:

Under 0.25 mm
25mm-0.3mm
75mm-1.0mm
1.0mm-1.5mm
Above 1.5mm

In Chapter 7, on the basis of applications, the Scalp Microneedling market from 2015 to 2025 covers:

Hair Transplant
Boost Hair
Others

Geographically, the detailed analysis of production, trade of the following countries is covered in Chapter 4.2, 5

United States
Europe
China
Japan
India

Geographically, the detailed analysis of consumption, revenue, market share and growth rate of the following regions are covered in Chapters 8, 9, 10, 11, 12

North America (Covered in Chapter 8)
United States
Canada
Mexico
Europe (Covered in Chapter 9)

The Middle East and Africa (Covered in Chapter 11)

Years considered for this report:

Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2025

2021-2027 Global Scalp Microneedling Market Report – Production and Consumption Professional Analysis (Impact of COVID-19)

Source

Recent Posts

Radical New Way to Treat Baldness

Radical New Way to Treat Baldness

Hair Follicles Can Smell Sandalwood, And It Could Be a Radical New Way to Treat Baldness

We tend to imagine smells as things that just float around us in the air, but there’s more to it than that.

What we perceive as the smell is actually an intersection between molecules called odorants (or aroma compounds) and olfactory receptors that are expressed by cells in our body, which send a signal to the brain when activated.

That whole process, in a nutshell, is the smell. But it turns out it’s not just our noses that can do it.

New research shows that human hair follicles express an olfactory receptor of their own called OR2AT4, and when OR2AT4 comes into contact with the molecular structure of a specific scent –synthetic sandalwood, as it turns out – it stimulates hair growth.

In other words, your hair – or rather your hair follicles – can ‘smell’, and if they sniff out the right chemical, it could be a radical new way of preventing hair loss.

“This is actually a rather amazing finding,” senior researcher and dermatologist Ralf Paus from the University of Manchester in the UK told The Independent.

“This is the first time ever that it has been shown that the remodelling of a normal human mini-organ [a hair] can be regulated by a simple, cosmetically widely-used odorant.”

Scientists already knew that OR2AT4 could be leveraged to promote keratinocyte proliferation in the skin (which promotes wound healing), leading Paus and his team to wonder whether olfactory receptors could be manipulated to also boost hair growth.

To find out, the researchers took samples of human scalp skin – donated by patients undergoing face-lift operations – and treated them with an application of synthetic sandalwood (aka Sandalore) in the lab.

Unlike authentic sandalwood, which doesn’t bind to OR2AT4, the team found synthetic sandalwood – used in personal care products to provide a sandalwood scent – does bind with the receptor, regulating expression and secretion of a key hair growth-promoting factor called IGF–1.

In other words, by promoting IGF–1, synthetic sandalwood stimulates the growing phase of hair cells, while helping to prevent them from dying.

When another chemical called Phenirat was mixed in to silence OR2AT4, it inhibited hair growing, suggesting the receptor plays a bigger part in hair growth than scientists previously knew.

The research was funded in part by an Italian pharmaceutical company that sells Sandalore in its products – which is something to bear in mind in light of the results.

But because of this pre-existing commercial availability of synthetic sandalwood, the team thinks their “olfactotherapy” discovery could end up helping patients sooner rather than later, if further clinical trials pan out.

According to Paus, the early signs of ongoing research are promising.

“A very small, short and preliminary clinical pilot study performed by an independent CRO [contract research organisation] in 20 female volunteers with topical Sandalore has already suggested a reduction of daily hair loss,” he says.

The next step is to see if that result can be replicated in a larger clinical trial, which the researchers hope to conclude in January next year.

We can’t get too carried away until we see what future tests bring, but according to Nicola Clayton of the British Association of Dermatologists, the initial data look exciting.

“It is a fascinating concept that the human hair follicle, as the authors put it, can ‘smell’ by utilising an olfactory receptor,” she told The Independent.

We’ll have to wait to see where this research leads from here, but if the team’s next trial is a success, we could be looking at an important new mechanism for hair loss prevention here.

Hair Follicles Can ‘Smell’ Sandalwood, And It Could Be a Radical New Way to Treat Baldness

Source

Recent Posts

Top Hair Restoration Surgeon

Top Hair Restoration Surgeon

World’s Leading Hair Transplant Surgeon Dr Alan J. Bauman Receives “#1 Top Hair Restoration Surgeon” and “Top Hair Restoration Surgeon of the Decade” in the Aesthetic Everything® Awards

Alan J. Bauman, MD, ABHRS, IAHRS, FISHRS was named “#1 Top Hair Restoration Surgeon” for the fifth consecutive year and “Top Hair Restoration Surgeon of the Decade” in the annual Aesthetic Everything® Awards.

World’s Leading Hair Transplant Surgeon Dr Alan J. Bauman Receives “#1 Top Hair Restoration Surgeon” and “Top Hair Restoration Surgeon of the Decade” in the Aesthetic Everything® Awards

His win in the Aesthetic and Cosmetic Medicine Awards is the most recent accolade of many earned by Dr Bauman. A full-time hair restoration physician and hair transplant surgeon, he is one of only some 200 physicians worldwide to achieve certification from the American and International Board of Hair Restoration Surgery. He is the first-ever hair transplant surgeon to be formally accepted as an Intercoiffure America Industry Partner, and amongst the elite surgeons accepted by the International Alliance of Hair Restoration Surgeons.

“For almost 25 years, I have devoted my practice to pioneering hair restoration procedures that improve the lives of those struggling with hair loss. This is our mission and the driving force of Bauman Medical. I’m honoured and humbled to be recognized as a five-time ‘#1 Top Hair Restoration Surgeon’ & ‘Top Hair Restoration Surgeon of the Decade,’ in the Aesthetic Everything® Awards.

I could not have achieved these goals without the devotion and support of my entire team at Bauman Medical. I wish to dedicate these awards to the 30,000 plus patients that have put their trust in me; they are the true inspiration for my work,” stated Dr. Bauman.

Dr Bauman founded Bauman Medical in 1997, a 12,000 sq ft “Hair Hospital” in Boca Raton, Florida. He is known for pioneering numerous technologies in the field of hair restoration, including minimally-invasive FUE Follicular Unit Extraction, VIP|FUETM No-Shave Hair Transplant, Low-Level Laser Therapy, PRP Platelet Rich Plasma, PDOgro™, Eyelash Transplants and others.

Dr Bauman’s compassionate, patient-oriented philosophy and individualized artistic approach to protecting, enhancing, and restoring the health and appearance of the hair and scalp has provided life-changing solutions for thousands of patients. He has treated over 30,000 patients, performed over 10,000 hair transplant procedures, and administered over 8,000 PRP treatments.

To learn more about Dr. Bauman and Bauman Medical, visit https://www.baumanmedical.com

About Aesthetic Everything®

Aesthetic Everything® is the largest network of aesthetic professionals in the world, a promotion source to the aesthetics industry.

World’s Leading Hair Transplant Surgeon Dr Alan J. Bauman Receives “#1 Top Hair Restoration Surgeon” and “Top Hair Restoration Surgeon of the Decade” in the Aesthetic Everything® Awards

Source

Recent Posts

Genetic Test for Hair Loss

Genetic Test for Hair Loss

The First Genetic Test for Hair Loss: Introducing TrichoTest, from Fagron

Fagron North America, a global leader in pharmaceutical compounding, debuts the most advanced genetic test supporting medical practitioners’ assessment and treatment of hair loss in the US: TrichoTest.*

TrichoTest is a genetic test performed on patients’ DNA that analyzes 13 genes and 48 genetic variations related to alopecia, including androgenetic alopecia, alopecia areata, and telogen effluvium. This genetic test is based on state-of-the-art DNA microarray technology and utilizes a patented algorithm to provide a personalized treatment recommendation to medical practitioners from 175 million therapeutic alternatives.

TrichoTest analyzes prostaglandins metabolism, inflammation, androgenic effect, vasodilation and blood circulation, collagen synthesis, vitamins and minerals metabolism, and insulin-like growth factor metabolism.

Introducing the most advanced genetic test supporting assessment and treatment of hair loss: TrichoTest, by Fagron.

Alopecia is a progressive and multifactorial condition related to endogenous and exogenous factors. Often, endogenous factors are genetics and are associated with gene expression. The most common type of hair loss, known as androgenetic alopecia, is hereditary. If left untreated, hair loss usually progresses over time.

TrichoTest is the most complete genetic test for alopecia, analyzing genetic factors and other relevant patient characteristics.

TrichoTest supports treatment efficacy. The test results can help medical practitioners develop a personalized treatment plan for their patients, which may include compounded topical solutions, oral supplements, and prescription hair care products.

Today, TrichoTest is the only complete genetic test for alopecia and hereditary hair loss in the US market.

About Fagron North America
Fagron North America (NA), a top-tier pharmaceutical supplier, is focused on creating the future of personalized medicine through investments in genomics, technology, pharmacy essentials and 503B outsourcing.

Fagron Inc., a Fagron NA brand, produces high-quality, innovative pharmaceutical raw materials, equipment, and supplies to prepare personalized medication in the pharmacy. Fagron Inc. offers a broad product portfolio across oral and topical compounding ingredients. As a global leader in pharmaceutical compounding, Fagron supports patient-focused medication that works to improve quality of life.

*TrichoTest is not approved by the Food and Drug Administration and is not intended to diagnose, treat, cure or prevent disease. Any recommendations given to the requesting medical practitioner are for informational purposes only and no individual is required to use any products mentioned in a report.

The First Genetic Test for Hair Loss: Introducing TrichoTest, from Fagron

Source

Recent Posts

Stem Cell and Platelet Rich Plasma (PRP) Alopecia

Stem Cell and Platelet Rich Plasma Alopecia

2021-2027 Global and Regional Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies

The research team projects that the Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies market size will grow from XXX in 2020 to XXX by 2027, at an estimated CAGR of XX. The base year considered for the study is 2020, and the market size is projected from 2020 to 2027.

The prime objective of this report is to help the user understand the market in terms of its definition, segmentation, market potential, influential trends, and the challenges that the market is facing with 10 major regions and 50 major countries.

Deep researches and analysis were done during the preparation of the report. The readers will find this report very helpful in understanding the market in depth. The data and the information regarding the market are taken from reliable sources such as websites, annual reports of the companies, journals, and others and were checked and validated by the industry experts.

The facts and data are represented in the report using diagrams, graphs, pie charts, and other pictorial representations. This enhances the visual representation and also helps in understanding the facts much better.

By Market Players:

Orange County Hair Restoration Center
Colorado Surgical Center & Hair Institute
Evolution Hair Loss Institute
Hair Sciences Center of Colorado
Hair Transplant Institute of Miami
Anderson Center for Hair
Virginia Surgical Center
Savola Aesthetic Dermatology Center

By Type

Platelet Rich Plasma Injections
Stem Cell Therapy

By Application

Dermatology Clinics
Hospitals

By Regions/Countries:

North America
United States
Canada
Mexico
East Asia
China
Japan
South Korea
Europe
Germany
United Kingdom
France
Italy
Russia
Spain
Netherlands
Switzerland
Poland
South Asia
India
Pakistan
Bangladesh
Southeast Asia
Indonesia
Thailand
Singapore
Malaysia
Philippines
Vietnam
Myanmar
Middle East
Turkey
Saudi Arabia
Iran
United Arab Emirates
Israel
Iraq
Qatar
Kuwait
Oman
Africa
Nigeria
South Africa
Egypt
Algeria
Morocoo
Oceania
Australia
New Zealand
South America
Brazil
Argentina
Colombia
Chile
Venezuela
Peru
Puerto Rico
Ecuador
Rest of the World
Kazakhstan

Points Covered in The Report

The points that are discussed within the report are the major market players that are involved in the market such as market players, raw material suppliers, equipment suppliers, end users, traders, distributors and etc.

The complete profile of the companies is mentioned. And the capacity, production, price, revenue, cost, gross, gross margin, sales volume, sales revenue, consumption, growth rate, import, export, supply, future strategies, and the technological developments that they are making are also included within the report. This report analyzed 12 years of data history and forecast.

The growth factors of the market is discussed in detail wherein the different end users of the market are explained in detail.

Data and information by market player, by region, by type, by application and etc, and custom research can be added according to specific requirements.

The report contains the SWOT analysis of the market. Finally, the report contains the conclusion part where the opinions of the industrial experts are included.

Key Reasons to Purchase

To gain insightful analyses of the market and have a comprehensive understanding of the global market and its commercial landscape.

Assess the production processes, major issues, and solutions to mitigate the development risk.

To understand the most affecting driving and restraining forces in the market and their impact on the global market.

Learn about the market strategies that are being adopted by leading respective organizations.

To understand the future outlook and prospects for the market.

Besides the standard structure reports, we also provide custom research according to specific requirements.

The report focuses on Global, Top 10 Regions and Top 50 Countries Market Size of Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies 2016-2021, and development forecast 2022-2027 including industries, major players/suppliers worldwide and market share by regions, with the company and product introduction, position in the market including their market status and development trend by types and applications which will provide its price and profit status, and marketing status & market growth drivers and challenges, with the base year as 2020.

Key Indicators Analysed

Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2021 & Sales by Product Types.

Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2022-2027. Further the report provides break down details about each region & countries covered in the report.

Identifying its production, consumption, import & export, sales volume & revenue forecast.

Market Analysis by Product Type: The report covers the majority of Product Types in the Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Industry, including its product specifications by each key player, volume, sales by Volume and Value (M USD).

Market Analysis by Application Type: Based on the Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Industry and its applications, the market is further sub-segmented into several major Applications of its industry. It provides you with the market size, CAGR & forecast by each industry application.

Market Trends: Market key trends include Increased Competition and Continuous Innovations.

Opportunities and Drivers: Identifying the Growing Demands and New Technology

Porters Five Force Analysis:

The report will provide the state of competition in the industry depends on five basic forces: the threat of new entrants, bargaining power of suppliers, bargaining power of buyers, the threat of substitute products or services, and existing industry rivalry.

COVID-19 Impact

The report covers Impact of Coronavirus COVID-19: Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost every country around the globe with the World Health Organization declaring it a public health emergency.

The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies market in 2021. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor/outdoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.

2021-2027 Global and Regional Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies

Source

Recent Posts